IDH1 and glioma: Using recombinant wt IDH1 and the most common IDHvariant in gliomas,27−30 IDH1 R132H, our biochemical and biophysical studies surprisinglyreveal a clear disconnection between inhibitory selectivity and bindingaffinity of the mIDH inhibitors for wt and R132H IDH1.